HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
Hepat Oncol
.
2020 Jun 22;7(2):HEP21.
doi: 10.2217/hep-2020-0010.
Authors
Devis Pascut
1
,
Muhammad Yogi Pratama
1
2
,
Claudio Tiribelli
1
Affiliations
1
Fondazione Italiana Fegato - ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149 Trieste, Italy.
2
Universitas Hasanuddin, Faculty of Medicine, Makassar, 90245, Indonesia.
PMID:
32647566
PMCID:
PMC7336296
DOI:
10.2217/hep-2020-0010
No abstract available
Keywords:
DAA; HCC; HCV; biomarkers; direct-acting antiviral.
Publication types
Editorial